-
1.发明申请MATERIAL AND METHODS FOR TREATING DEVELOPMENTAL DISORDERS INCLUDING COMORBID AND IDIOPATHIC AUTISM 有权治疗发展中疾病的材料与方法，包括呼吸道感染和心脏病公开(公告)号：US20160303057A1
公开(公告)日：2016-10-20
申请号：US15192535
申请日：2016-06-24
Inventor： Craig A. Erickson
IPC: A61K31/16
CPC classification number: A61K31/16 , A61K31/185 , A61K31/4035
Abstract: Subjects who were diagnosed with either comorbid or idiopathic autism were treated with acamprosate. Patients generally showed marked improvements in primary outcomes as assessed using, for example, standard clinic measures for functionality including the Clinical Global Impressions Improvement (CGI-I) and the Clinical Global Impressions Severity (CGI-S) scales.
Abstract translation: 被诊断患有合并症或特发性自闭症的受试者用acamprosate治疗。 通过使用例如临床全球印象改善（CGI-I）和临床全球印象严重程度（CGI-S）量表的功能的标准诊所措施进行评估，患者通常显示出主要结局的显着改善。
-
2.发明授权公开(公告)号：US09956189B2
公开(公告)日：2018-05-01
申请号：US15192535
申请日：2016-06-24
Inventor： Craig A. Erickson
IPC: A61K31/16 , A61K31/185 , A61K31/4035
CPC classification number: A61K31/16 , A61K31/185 , A61K31/4035
Abstract: The present invention is directed to a method of treating a subject with autism spectrum disorder by administering an acetylaminopropane sulfonate. The acetylaminopropane sulfonate may have the following formula
-
Search Results
2
records
(took 0.013 seconds)
